Economic cost associated with type II diabetes in Spanish patients

European Journal of Health Economics

Volumn 7, Issue 4, 2006, Pages 270-275

  Ballesta, Miguel ^a   Carral, Florentino ^b   Olveira, Gabriel ^c   Girón, José Antonio ^b   Aguilar, Manuel ^b  

^a Centro de Salud 'La Paz'   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Complications; Cost; Diabetes type II; Economic costs; Metabolic control

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISABILITY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH SURVEY; HOSPITALIZED ADOLESCENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SPAIN; VASCULAR DISEASE;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SPAIN;

EID: 33847333954     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-006-0367-9     Document Type: Article

References (26)

1. King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431
2. Carral F, Olveira G, Ramos I et al. (2000) Calidad de vida en pacientes con diabetes mellitus tipo 2 ingresados en un hospital de tercer nivel. Endocrinol Nutr 47: 24-28
3. Eiser C, Tooke JE (1993) Quality-of-life evaluation in diabetes. Pharmacoeconomics 4: 85-91
4. Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78: 809A-809F
5. American Diabetes Association (2003) Economic costs of diabetes in the United States in 2002. Diabetes Care 26: 917-932
6. American Diabetes Association (1998) Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 21: 296-309
7. Kangas T, Aro S, Koivisto VA et al. (1996) Structure and costs of health care of diabetic patients in Finland. Diabetes Care 19: 494-497
8. Gisbert R, Brosa M (1998) Costes sanitarios y evaluación económica. SOIKOS: Barcelona
9. Mata M, Antoñanzas F, Tafalla M, Sanz P (2002) El coste de la diabetes tipo 2 en España. El estudio CODE-2. Gac Sanit 16: 511-520
10. Krosnick A (1988) Economic impact of type II diabetes mellitus. Prim Care 15: 423-432
11. Henriksson F, Jönsson B (1998) Diabetes: the cost of illness in Sweden. J Intern Med 244: 461-468
12. Norlund A, Apelqvist J, Bitzén O et al. (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250: 57-65
13. Persson U (1995) The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 8 [Suppl 1]: 28-32
14. Peisker P (1999) Vademecum Internacional 40 Edición. Medicom: Madrid
15. Anonymous (2000) Consejería de Salud del Gobierno Canario. Memoria estadística
16. García F, Molins G, Farre J et al. (1995) La contabilidad de coste en atención primaria: cartera de servicios. Aten Primaria 16: 141-145
17. Carral F, Olveira G, Salas J et al. (2002) Estimate of care resource utilization incurred by diabetic patients in a Spanish hospital. Diab Res Clin Pract 56: 27-34
18. Ministerio de Trabajo y Asuntos Sociales (2000) Encuesta de salarios ESA-14. Ministerio de Trabajo y Asuntos Sociales: Madrid
19. Anonymous (nd) Pensiones contributivas del Sistema de Seguridad Social. Ministerio de trabajo y asuntos sociales: Madrid
20. Brandle M, Zhou H, Smith BRK et al. (2003) The direct medical cost of type 2 diabetes. Diabetes Care 26: 2300-2304
21. Redekop WK, Koopmanschap MA, Rutten GE et al. (2002) Resource consumption and costs in Dutch patients with type 2 diabetes mellitus: results from 29 general practices. Diabet Med 19: 246-253
22. Jonsson B, CODE-2 Advisory Board (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45: S5-12
23. Olveira G, Olvera P, Carral F et al. (2004) Excess cost due to hospitalization of persons with diabetes in Andalucía (Spain). Diabetes Care 27: 1904-1909
24. Gilmer TP, O'Connor PJ, Manning WG, Rush WA (1997) The cost to health plans of poor glycemic control. Diabetes Care 20: 1847-1853
25. Wagner EH, Sandhu N, Newton KM et al. (2001) Effect of improved glycemic control on health care costs and utilization. JAMA 285: 182-189
26. Gray A, Raikou M, McGuire A et al. (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 320: 1373-1378